An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.
HHS dispatches millions to next-generation Covid targets, including intranasal vaccine
WASHINGTON — The Biden administration announced Friday that it is investing in three potential vaccines and a range of new technologies aimed at staying ahead